Pandemic Restrictions Reduce Hepatitis C Testing and Treatment
The impact of such a significant decrease in HCV testing and treatment affects both the individual patients and public health as a whole.
Read MoreA Gap in Diagnosis of Hep C Infections During the Opioid Epidemic
Federally qualified health centers see 10 times the HCV prevalence of the general population, but aren’t yet reaching their full potential in fighting this consequence of the opioid epidemic.
Read MoreFighting Hepatitis A With Vaccines in the Emergency Department
A pharmacy-led campaign to boost vaccinations highlight the important role of pharmacists and the ED in public health emergencies.
Read MoreStudy: Improvements Needed for Hepatitis C Testing in Youth
The opioid epidemic is fueling an increase in hepatitis C in the Unites States, especially among younger demographics. Data from the Centers for Disease Control and Prevention (CDC) reveal that in 2016, 9.1% of all people with chronic hepatitis C virus (HCV) infection were between the ages of 15 and 24 — up from 3.8%…
Read More